Parameters of macrophage reaction and humoral immunity in patients with implant-associated in-flammation after primary endoprosthetics of knee joint

Abstract

Aim. To study peculiarities of macrophage reaction and humoral immunity in patients with signs of implant-associated inflammation after the primary endoprosthetics of the knee joint.

Materials and Methods. Examination of 48 patients with signs of implant-associated inflammation after the primary endoprosthetics of the knee joints (the main group) and of 44 patients without signs of inflammatory reactions (comparison group) was carried out. Control group involved 30 healthy donors without diseases of the musculoskeletal system.

Results. In 1 and 12 months after the surgery, patients of the main group showed elevated levels of the factor inhibiting migration of macrophages (MIF), of macrophage stimulating protein (MSP), class A immunoglobulins (IgA), С₃ and С₄ complement components as compared to control, and also to each previous period. In 1 month after the surgery, the content of class M and G immunoglobulins (IgM and IgG) decreased relative to control; in 12 months after the surgery a more pronounced reduction was noted. Increase in serum concentrations of MIF, MSP, IgA, С₃ and С₄-complement components was noted in the comparison group in 1 and 12 months and also in comparison with the previous period. Reduction of the levels of IgM, IgG in 1 and 12 months after the operation was noted in comparison with control and with the previous period.

Conclusion. A study of parameters of macrophage reaction, proteins of complement system and the main classes of immunoglobulins permits to identify signs of implant-associated inflammation in 1 and 12 months after surgery, and, consequently, to determine patients of risk groups that require additional diagnostics measures.

Keywords

knee joint / primary endoprosthetics / macrophage reaction / humoral immunity / implant-associated inflammation

References

[1] Bolotkan uulu Nasyr. Prophylaxis of infectious complications of endoprothesis of knee joint. Vestnik KSMA im. I.K. Akhunbayeva. 2015;(1):69-73. (In Russ).

[2] Болоткан уулу Насыр. Профилактика инфекционных осложнений эндопротезирования коленного сустава (обзор) // Вестник КГМА им. И.К. Ахунбаева. 2015. №1. С. 69-73.

[3] Filipenko VA, Marushchak AP, Bondarenko SYe. Periprosthetic infection: diagnostic and treatment. Part I (literature review). Orthopaedics, Traumatology and Prosthetics. 2016;(2):102-9. (In Russ).

[4] Филиппенко В.А., Марущак А.П., Бондаренко С.Е. Перипротезная инфекция: диагностика и лечение. Часть 1 (обзор литературы) // Ортопедия, травматология и протезирование. 2016. №2. С. 102-109.

[5] Tikhomirov DA, Schekolova NB. Experience of treatment of infectious complications after primary hip joint endoprosthesis replacement. Permskiy Meditsinskiy Zhurnal. 2016;33(4):28-32. (In Russ).

[6] Тихомиров Д.А., Щеколова Н.Б. Опыт лечения инфекционных осложнений после первичного эндопротезирования тазобедренного сустава // Пермский медицинский журнал. 2016. Т. 33, №4. С. 28-32.

[7] Tsibulkina VN, Akhtyamov, IPh, Kilmetov TA. Immunological aspects of pyoinflammatory complications after endoprosthesis replacement of large joints. Practical Medicine. 2016;(4-2):161-4. (In Russ).

[8] Цибулькина В.Н., Ахтямов И.Ф., Кильметов Т.А. Иммунологические аспекты гнойно-воспалительных осложнений эндопротезирования крупных суставов // Практическая медицина. 2016. №4-2. С. 161-164.

[9] Shakhidzhanov SS, Filippova AE, Butilin AA, et al. A modern view on the complement system. Pediatric Hematology/Oncology and Immunopathology. 2019;18(3):133-40. (In Russ). doi:10.24287/1726-1708-2019-18-3-130-144

[10] Шахиджанов С.С., Филиппова А.Е., Бутылин А.А., и др. Современное представление о системе комплемента // Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2019. Т. 18, №3. С. 133-144. doi:10.24287/1726-1708-2019-18-3-130-144

[11] Litvitskiy PF, Sinel'nikova TG. Innate immunity: mechanisms of realization and pathological syndromes. Part III. Voprosy Sovremennoi Pediatrii. 2009;8(3):54-65. (In Russ).

[12] Литвицкий П.Ф., Синельникова Т.Г. Врожденный иммунитет: механизмы реализации и патологические синдромы. Часть 3 // Вопросы современной педиатрии. 2009. Т. 8, №3. С. 54-65.

[13] Galashina EA, Ulyanov VYu, Gladkova EV, et al. Comparative analysis of the change of bone tissue metabolism condition and cytokine profiles in patients with endoprosthesis instability after primary knee arthroplasty. I.P. Pavlov Russian Medical Biological Herald. 2020;28(1):5-12. (In Russ). doi: 10.23888/PAVLOVJ20202815-12

[14] Галашина Е.А., Ульянов В.Ю., Гладкова Е.В., и др. Сопоставительный анализ изменений состояния метаболизма костной ткани и цитокинового профиля у пациентов с нестабильностью эндопротеза после первичной артропластики ко-ленного сустава // Российский медико-биологический вестник имени академика И.П. Павлова. 2020. Т. 28, №1. С. 5-12. doi:10.23888/PAVLOVJ20202815-12

[15] Vodopyanov AS, Dudnikova EV, Dergousova MS, et al. The role of macrophage migration inhibitory factor in chronization of pathological process (references). Meditsinskiy Vestnik Yuga Rossii. 2013; (3):4-7. (In Russ).

[16] Водопьянов А.С., Дудникова Э.В., Дергоусова М.С., и др. Роль фактора, ингибирующего ми-грацию макрофагов, в хронизации патологического процесса (обзор литературы) // Медицинский вестник Юга России. 2013. №3. С. 4-7.

[17] Rampino Т, Сollesi C, Gregorini M, et al. Macrophage-stimulating protein is produced by tubular cells and activates mesangial cells. Journal of the American Society of Nephrology. 2002;13(3):649-57.

[18] Rampino Т., Сollesi C., Gregorini M., et al. Macro-phage-stimulating protein is produced by tubular cells and activates mesangial cells // Journal of the American Society of Nephrology. 2002. Vol. 13, №3. P. 649-657.

[19] Gladkova EV, Mamonova IA, Babushkina IV, et al. The features of immune status in elderly and senile patients after total replacement of large joints. International Journal of Applied and Fundamental Research. 2017;(6 Pt 1):107-10. (In Russ).

[20] Гладкова Е.В., Мамонова И.А., Бабушкина И.В., и др. Особенности иммунного статуса пациентов пожилого и старческого возраста после тотального эндопротезирования крупных суставов // Международный журнал прикладных и фундаментальных исследований. 2017. №6, Часть 1. С. 107-110.

[21] Chebotar IV. Mechanisms of antibiofilm immunity. Annals of the Russian academy of medical sciences. 2012;(12):22-9. (In Russ).

[22] Чеботарь И.В. Механизмы антибиопленочного иммунитета // Вестник Российской академии медицинских наук. 2012. №12. С. 22-29.

[23] Kilmetov ТА, Lapshina SA, Ardashev SA. Infectious complications after replacement of a large joints. Practical Medicine. 2015;1(4):76-8. (In Russ).

[24] Кильметов Т.А., Лапшина С.А., Ардашев С.А. Инфекционные осложнения после эндопротезирования крупных суставов // Практическая медицина. 2015. Т. 1, №4. С. 76-78.

[25] Pan X, Mao X, Cheng T, et al. Upregulated expression of MIF by interfacial membrane fibroblasts and macrophages around aseptically loosened implants. The Journal of Surgical Research. 2012;176(2):484-9. doi:10.1016/j.jss.2011.09.047

[26] Pan X., Mao X., Cheng T., et al. Up-regulated expression of MIF by interfacial membrane fibro-blasts and macrophages around aseptically loosened implants // The Journal of Surgical Research. 2012. Vol. 176, №2. P. 484-489. doi:10.1016/j.jss. 2011.09.047

[27] Thordardottir S, Vikingsdottir T, Bjarnadottir H, et.al. Activation of Complement Following Total Hip Replacement. Scandinavian Journal of Immunology. 2016;83(3):219-24. doi:10.1111/sji.12411

[28] Thordardottir S., Vikingsdottir T., Bjarnadottir H., et al. Activation of Complement Following Total Hip Replacement // Scandinavian Journal of Immunology. 2016. Vol. 83, №3. P. 219-224. doi:10.1111/sji.12411

RIGHTS & PERMISSIONS

Eco-Vector